Li Long, Age 63Woburn, MA

Li Long Phones & Addresses

Woburn, MA

Arlington, MA

Burlington, MA

Pleasant Hill, OR

3 Old Oregon Trl, Acton, MA 01720

Manchester, NH

Providence, RI

Show more

Mentions for Li Long

Li Long resumes & CV records

Resumes

Li Long Photo 39

Li Hong Long

Li Long Photo 40

Li Long

Publications & IP owners

Wikipedia

Li Long Photo 41

Li Lg

Li Long (, Ri Ron?) is a fictional character in the Soul series of video games. Created by Namco 's Project Soul division, he first appeared in Soul Edge, later ...

Us Patents

M-Csf Specific Monoclonal Antibody And Uses Thereof

US Patent:
2019026, Aug 29, 2019
Filed:
Oct 12, 2018
Appl. No.:
16/158642
Inventors:
- Emeryville CA, US
Gregory Martin Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
William Michael Kavanaugh - Orinda CA, US
Li Long - Lafayette CA, US
Arnold Horwitz - Los Angeles CA, US
International Classification:
C07K 16/24
A61K 39/395
A61K 31/663
A61K 45/06
A61K 31/675
Abstract:
M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

M-Csf Specific Monoclonal Antibody And Uses Thereof

US Patent:
2018017, Jun 21, 2018
Filed:
Feb 7, 2018
Appl. No.:
15/891051
Inventors:
- Emeryville CA, US
- Berkeley CA, US
Gregory Martin Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
William Michael Kavanaugh - Orinda CA, US
Li Long - Lafayette CA, US
Arnold Horwitz - San Leandro CA, US
International Classification:
C07K 16/24
A61K 31/675
A61K 31/663
A61K 39/395
Abstract:
M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

M-Csf Specific Monoclonal Antibody And Uses Thereof

US Patent:
2017015, Jun 1, 2017
Filed:
Nov 9, 2016
Appl. No.:
15/347171
Inventors:
- Emeryville CA, US
- Berkeley CA, US
Gregory Martin Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
William Michael Kavanaugh - Orinda CA, US
Li Long - Lafayette CA, US
Arnold Horwitz - San Leandro CA, US
Assignee:
NOVARTIS VACCINES AND DIAGNOSTICS INC. - Emeryville CA
XOMA TECHNOLOGY LTD. - Berkeley CA
International Classification:
C07K 16/24
A61K 31/663
A61K 31/675
A61K 39/395
Abstract:
M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

M-Csf Specific Monoclonal Antibody And Uses Therof

US Patent:
2016001, Jan 21, 2016
Filed:
Jun 3, 2015
Appl. No.:
14/729548
Inventors:
- Emeryville CA, US
- Berkeley CA, US
Gregory Martin Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
William Michael Kavanaugh - Orinda CA, US
Li Long - Lafayette CA, US
Arnold Horwitz - San Leandro CA, US
Assignee:
NOVARTIS VACCINES AND DIAGNOSTICS INC. - Emeryville CA
XOMA TECHNOLOGY LTD. - Berkeley CA
International Classification:
A61K 39/395
A61K 45/06
C07K 16/24
Abstract:
M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

M-Csf Specific Monoclonal Antibody And Uses Thereof

US Patent:
2014024, Aug 28, 2014
Filed:
Feb 3, 2014
Appl. No.:
14/171330
Inventors:
- Berkeley CA, US
- Emeryville CA, US
Gregory Martin Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
William M. Kavanaugh - Orinda CA, US
Li Long - Lafayette CA, US
Arnold Horwitz - San Leandro CA, US
Assignee:
XOMA TECHNOLOGY LTD. - Berkeley CA
NOVARTIS VACCINES AND DIAGNOSTICS INC. - Emeryville CA
International Classification:
C07K 16/24
A61K 31/663
A61K 39/395
US Classification:
4241331, 5303873, 5303879, 4241391
Abstract:
M-CSF-specific RX1-based or RX-1 derived antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.